Human lymphoblastoid cell line panels: Novel tools for assessing shared drug pathways

Pharmacogenomics

Volumn 11, Issue 3, 2010, Pages 327-340

  Morag, Ayelet ^a   Kirchheiner, Julia ^b   Rehavi, Moshe ^a   Gurwitz, David ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Anticancer drug; Antipsychotic; Cell growth inhibition; Chlorpheniramine; Drug pathway; Gene expression profiling; Goodness of fit of linear regression; Human lymphoblastoid cell line; Resveratrol; Serotonin reuptake inhibitor antidepressant; Steroid drug

Indexed keywords

AMITRIPTYLINE; AZATHIOPRINE; BECLOMETASONE; CHLORPHENIRAMINE; CITALOPRAM; CLOZAPINE; DEXAMETHASONE; FLUOROURACIL; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; MERCAPTOPURINE; METHOTREXATE; PAROXETINE; PREDNISOLONE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DENSITY; CELL DIVISION; CELL GROWTH; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TARGETING; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMIDITY; LYMPHOBLASTOID CELL LINE;

ANTIDEPRESSIVE AGENTS; ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; CELL LINE; CELL PROLIFERATION; CHLORPHENIRAMINE; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; HUMANS; LYMPHOCYTES; METABOLIC NETWORKS AND PATHWAYS; PHARMACOGENETICS; SEROTONIN UPTAKE INHIBITORS; STEROIDS;

EID: 77949646357     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.27     Document Type: Article

References (33)

1. Lamb J, Crawford ED, Peck D et al.: The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935 (2006).
2. Michnick SW: The Connectivity Map. Nat. Chem. Biol. 2(12), 663-664 (2006).
3. Lamb J: The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer 7(1), 54-60 (2007).
4. Hernandez-Boussard T, Whirl-Carrillo M, Hebert JM et al.: The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res. 36, D913-D918 (2008).
5. Sangkuhl K, Berlin DS, Altman RB, Klein TE: PharmGKB: understanding the effects of individual genetic variants. Drug Metab. Rev. 40(4), 539-551 (2008).
6. Keiser MJ, Setola V, Irwin JJ et al.: Predicting new molecular targets for known drugs. Nature 462, 175-181 (2009).
7. Miller G: Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man. Yale J. Biol. Med. 43(6), 358-384 (1971).
8. Sie L, Loong S, Tan EK: Utility of lymphoblastoid cell lines. J. Neurosci. Res. 87(9), 1953-1959 (2009).
9. Shukla SJ, Duan S, Badner JA, Wu X, Dolan ME: Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Pharmacogenet. Genomics 18(3), 253-262 (2008).
10. Bleibel WK, Duan S, Huang RS et al.: Identifcation of genomic regions contributing to etoposide-induced cytotoxicity. Hum. Genet. 125(2), 173-180 (2009).
11. Hartford CM, Duan S, Delaney SM et al.: Population-specifc genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. Blood 113(10), 2145-2153 (2009).
12. Fry RC, Svensson JP, Valiathan C et al.: Genomic predictors of interindividual differences in response to DNA damaging agents. Genes Dev. 22, 2621-2626 (2008).
13. Li L, Fridley B, Kalari K et al.: Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. Cancer Res. 68(17), 7050-7058 (2008).
14. Choy E, Yelensky R, Bonakdar S et al.: Genetic ana lysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet. 4(11), E1000287 (2008).
15. Zhang W, Huang RS, Duan S, Dolan ME: Gene set enrichment analyses revealed differences in gene expression patterns between males and females. In Silico Biol. 9(3), 55-63 (2009).
16. Abdul M, Logothetis CJ, Hoosein NM: Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J. Urol. 154(1), 247-250 (1995).
17. Volpe DA, Ellison CD, Parchment RE, Grieshaber CK, Faustino PJ: Effects of amitriptyline and fuoxetine upon the in vitro proliferation of tumor cell lines. J. Exp. Ther. Oncol. 3(4), 169-184 (2003).
18. Rosetti M, Frasnelli M, Tesei A, Zoli W, Conti M: Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells. J. Exp. Ther. Oncol. 6(1), 23-29 (2006).
19. Serafeim A, Holder MJ, Grafton G et al.: Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101(8), 3212-3219 (2003).
20. Schuster C, Fernbach N, Rix U et al.: Selective serotonin reuptake inhibitors-a new modality for the treatment of lymphoma/leukaemia? Biochem. Pharmacol. 74(9), 1424-11235 (2007).
21. Gurwitz D, Kimchi O, Bonne-Tamir B: The Israeli DNA and Cell Line Collection: A Human Diversity Repository. In: Populations and Genetics. Legal and Socio-Ethical Perspectives. Knoppers BM (Ed.). Martinus Nijhoff, Leiden, The Netherlands 95-113 (2003).
22. Gillman PK: Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br. J. Pharmacol. 151(6), 737-748 (2007).
23. Barkan T, Gurwitz D, Levy G, Weizman A, Rehavi M: Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes. Eur. Neuropsychopharmacol. 14(3), 237-243 (2004).
24. Lee MH, Choi BY, Kundu JK et al.: Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res. 69(18), 7449-7458 (2009).
25. Sahasranaman S, Howard D, Roy S: Clinical pharmacology and pharmacogenetics of thiopurines. Eur. J. Clin. Pharmacol. 64(8), 753-767 (2008).
26. Hellbom E: Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment. Med. Hypotheses 66(4), 689-690 (2006).
27. Carlsson A, Linqvist M: Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J. Pharm. Pharmacol. 21, 460-464 (1969).
28. Alisky JM: Can chlorpheniramine cause serotonin syndrome? Singapore Med. J. 47(11), 1014 (2006).
29. Rangrej J, Beyene J, Hu P, Paterson AD: Sex, age and generation effects on genome-wide linkage ana lysis of gene expression in transformed lymphoblasts. BMC Proc. 1(Suppl. 1), S92 (2007)
30. Duan S, Huang RS, Zhang W et al.: Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines. Pharmacogenomics 10(4), 549-563 (2009).
31. Brennan EP, Ehrich M, Brazil DP et al.: Comparative ana lysis of DNA methylation profles in peripheral blood leukocytes versus lymphoblastoid cell lines. Epigenetics 4(3), 159-164 (2009).
32. Gurwitz D, Weizman A: Personalized psychiatry: a realistic goal. Pharmacogenomics 5(2), 213-217 (2004).
33. Kirchheiner J, Seeringer A, Viviani R: Pharmacogenetics in psychiatry-a useful clinical tool or wishful thinking for the future? Curr. Pharm. Des. (2009) (Epub ahead of print